Table II.
Group | Case | Ventilator application time (days) | VAP | VILI | Ventilator associated complications |
---|---|---|---|---|---|
Control group | 30 | 8.7±1.3 | 6 | 3 | 9 (30.0) |
Observation group | 32 | 5.6±1.2 | 2 | 1 | 3 (9.4) |
t (χ2) | 5.947 | 4.220 | |||
P-value | 0.028 | 0.040 |
VAP, ventilator-associated pneumonia; VILI, ventilator-induced lung injury.